ArticleResearch in cardiovascular medicine2016
Menstrual Disturbances in Women With Congenital Heart Diseases.
Article in Research in cardiovascular medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 16 citations in OpenAlex.
- Menstrual Health in Adolescents with Congenital Heart DiseaseJournal of clinical research in pediatric endocrinology · 2026Article
- Menstrual disturbances in women with advanced heart failure and heart transplant recipients.Frontiers in cardiovascular medicine · 2025Article
- Association of heavy menstrual bleeding with cardiovascular disease in US female hospitalizations.BMC medicine · 2024Article
- Access to Specialized Care Across the Lifespan in Tetralogy of Fallot.CJC pediatric and congenital heart disease · 2023Review
- Gynaecological health in adult congenital heart disease women: Addressing menorrhagia, infertility, contraception, menopause.International journal of cardiology. Congenital heart disease · 2023Review
- Timing of Pubertal Development in Boys and Girls With Congenital Heart Defects: A Nationwide Cohort Study.Journal of the American Heart Association · 2022Article
- Reduced ovarian function in women with complex congenital heart disease.International journal of cardiology. Congenital heart disease · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWomen with congenital heart disease (CHD) may experience menstrual disturbances secondary to hemodynamic instability during the mensturation phase.
objectivesWe investigated the menstrual bleeding pattern and its relationship with certain clinical findings in adult women with CHD. PATIENTS AND
methodsClinical data and menstrual bleeding pattern of adult women ≥15 years old who were referred to adult CHD clinic between March and September 2014 were recorded. Patients with syndromic congenital anomalies were excluded.
resultsData of 304 women (151 and 153 with simple and complex CHD groups, respectively) were recorded. Their mean (SD) age was 25.2 (1) years (range, 15 - 46 years). The median (IQR) age at menarche was 13 (12 - 14.25) years. Menarche was later in patients with CHD than in the normal population. Furthermore, the simple group showed earlier menarche than the complex group. The most common menstrual abnormality was menorrhagia in both groups (14.5% and 20.5% in the simple and complex groups, respectively). The incidence of menstrual abnormality was higher, though not significantly, in the complex group (40% vs. 25% in the simple group; P = 0.2). Menorrhagia was associated with the severity of oxygen desaturation (P = 0.007).
conclusionsMenstrual abnormalities are common in women with CHD, and therefore this group of patients should be aware of the menstrual function and its abnormalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.